FibroBiologics Inc. Commo...

NASDAQ: FBLG · Real-Time Price · USD
0.57
-0.02 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.57
-1.21%
After-hours: Aug 15, 2025, 05:55 PM EDT

FibroBiologics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.16M -16.48M -5.12M -1.58M
Depreciation & Amortization
573K 437K 94K n/a
Stock-Based Compensation
2.22M 1.76M 265K n/a
Other Working Capital
-694K 352K 307K 172K
Other Non-Cash Items
-4.09M 7.39M 842K n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
559K 493K 307K 172K
Operating Cash Flow
-11.9M -6.4M -4.07M -1.41M
Capital Expenditures
-184K -495K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-184K -495K n/a n/a
Debt Repayment
9.4M n/a 3.77M 1.52M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -2.35M 2.15M 292K
Financial Cash Flow
16.91M 13.79M 5.92M 1.82M
Net Cash Flow
4.82M 6.9M 1.86M 407K
Free Cash Flow
-12.09M -6.9M -4.07M -1.41M